about
sameAs
Lenalidomide and Blinatumomab in Treating Patients With Relapsed Non-Hodgkin LymphomaBlinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaAnti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host DiseaseDonor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood DiseasesOral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C SubjectsCytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain TumorsBone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow TransplantMonoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic CancerAnti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic LeukemiaBlinatumomab in Combination With Chemotherapy in Treating Patients With or Without Down Syndrome and Newly Diagnosed, Standard Risk B-Lymphoblastic Leukemia or Localized B-Lymphoblastic Lymphoma
P4844
Q61862236-9008D1F9-9A81-40FF-A27E-08F430E09408Q61864749-1A721979-5485-4425-A7E6-4C494A9E95A8Q61914919-ADB99057-F140-43F1-B10B-C5C7F6DAB98DQ61921024-422D3151-79AF-48C7-B746-054AD3B74EB5Q61965787-DDBC7573-FE39-4FAA-A624-DAA043550052Q62110212-A2FAC02F-C14C-442A-9BA7-E09A2475DD0DQ62110238-E03F1199-1B80-454E-ABC9-B5752126205EQ62110561-F1B9737D-8387-4DCB-8623-8C1AB387D223Q63322197-AA5FFA71-AD18-4940-BB38-5F6F4CE4F950Q63574324-B09F3D7C-B344-4639-AD73-859BC4CB745DQ63578202-CBF5071A-14A3-4297-96EB-34CB94080621
P4844
description
Protein
@de
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Muromonab CD3
@pt
Muromonab
@en
Muromonab
@it
Muromonab-CD3
@de
Muromonab-CD3
@es
Muromonab-CD3
@fr
Muromonab-CD3
@nl
Muromonab-CD3
@pl
Muromonab-CD3
@sh
Muromonab-CD3
@sr
type
label
Muromonab CD3
@pt
Muromonab
@en
Muromonab
@it
Muromonab-CD3
@de
Muromonab-CD3
@es
Muromonab-CD3
@fr
Muromonab-CD3
@nl
Muromonab-CD3
@pl
Muromonab-CD3
@sh
Muromonab-CD3
@sr
altLabel
Anti-CD3
@en
Muromonab
@de
Muromonab
@es
Muromonab
@pl
Muromonab-CD3
@en
Muromonab-CD3
@it
OKT-3
@en
OKT3
@es
Orthoclone OKT3
@pl
Orthoclone OKT3
@pt
prefLabel
Muromonab CD3
@pt
Muromonab
@en
Muromonab
@it
Muromonab-CD3
@de
Muromonab-CD3
@es
Muromonab-CD3
@fr
Muromonab-CD3
@nl
Muromonab-CD3
@pl
Muromonab-CD3
@sh
Muromonab-CD3
@sr
P31
P486
P592
P6366
P646
P665
P2167
P2275
muromonab-CD3
@en
P231
140608-64-6
P267
P3117
DTXSID2046414
P486
P592
CHEMBL1201608
P6366
2777756902
P646
P652
JGA39ICE2V